期刊文献+

氟伐他汀对高血压患者脉压和动脉弹性的影响 被引量:2

Effects of Fluvastatin on the pulse pressure and arterial elasticity of hypertensive patientsEffects of Fluvastatin on the pulse pressure and arterial elasticity of hypertensive patients
下载PDF
导出
摘要 目的评价氟伐他汀对高血压患者脉压和动脉弹性的影响。方法选择60例正在规律服用降压药物治疗并且脉压≥60mmHg的高血压患者,随机分成治疗组和对照组,每组各30例。治疗组在服用原降压药物的基础上加服氟伐他汀(40mg/d),对照组则继续服用原降压药物不变,在治疗前及治疗16周以后分别检测患者的血压、大动脉和小动脉弹性指数(C1和C2)。结果氟伐他汀组治疗后收缩压(135.2±12.6)mmHg、脉压(59.5±8.6)mmHg和C2(5.0±2.8)mmHg较对照组收缩压(143,4±14.7)mmHg、脉压(70.2±10.8)mmHg和C2(3.2±1.8)mmHg明显改善(P〈0.05),C1则无显著改变(P〉0.05)。结论氟伐他汀能明显改善高血压患者的小动脉弹性,从而起到降低脉压的作用。 Objective To investigate the effects of Fluvastatin on the pulse pressure and arterial elasticity of hypertensive patients, nothods 60 hypertensive patients who take hypotensor regularly and with a pulse pressure higher than 60 mm Hg were chosen in this study. These patients were divided into treatment group and reference group in a random way (30 people for each). Patients in treatment group take Fluvastatin additionally on the basis of existing hypotensor (40 mg/d), while the reference group continuous to take hypotensor constantly. Blood pressures, aortic and arteriolar elasticity indexes(C1 and C2) were measured separately before, during and after 16 weeks of treatment. Results The systolic blood pressure(SBP), pulse pressure(PP) and arteriolar elasticity index (C2) of the patients who received Flucastatin treatment were obviously improved (P〈0.05) than reference group. However, the C1 index has no significant improvement(P〉0.05) compared with reference group. Conclusion Fluvastatin can obviously improve the arteriolar elasticity in hypertensive patient, therefore can decrease pulse pressure (PP).
作者 宋秀荣 王永
出处 《中国心血管病研究》 CAS 2011年第1期22-23,33,共3页 Chinese Journal of Cardiovascular Research
关键词 氟伐他汀 高血压 脉压 动脉弹性 Fluvastatin Hypertension Pulse pressure Arterial elasticity
  • 相关文献

参考文献5

二级参考文献19

  • 1沈洪,周京敏.C-反应蛋白与冠心病[J].心血管康复医学杂志,2005,14(2):181-183. 被引量:6
  • 2[33]Executive Summary of the Third Report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blcocl Cholesterol in Adults (Adult Treatment Panel Ⅲ ) [J ].JAMA, 2001,285: 2486 - 2497
  • 3[34]Ridker PM. High- sensitivity C- reactive Protein:Potential adjunct for global risk assessment in the primary prevention of Cardiovascular disease [ J ]. Circulation,2001,103:1813 - 1818
  • 4[35]Braunwald E. Shattuch Lecture- cardiovascular medicine at the turn of the millennium: triumphs, concerns nd opportunities[J]. N Engl J Med, 1997,337:1360- 1369
  • 5[36]Ridker PM, Rifai N, Pfeifer MA, et al. Long - term effects of pravastatin on plasma concentration of C- reactive protein[ J ]. Circulation, 1999,100: 230 - 235
  • 6[37]Jialal I,Stein D,Balis D,et al. Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C - reactive protein levels [ J]. Circulation,2001,103:1933 - 1935
  • 7Grundy SM,Clemen JI,Mers CN,et al.Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guideline,Circulation,2004,110(2):227
  • 8Cannon CP,Braunwald E,McCabe CH,et al.Intensive versus Moderate lipid lowering with statins after acute coronary sysdromes.N Engl Med,2004,350(15):1495
  • 9Shepherd J,Blauw GJ,Murphy MB,et al.Pravastatin in elderly individuals at risk of vascular disease:a randomized controlled trial.Lancet,2002,360:1623
  • 10Pearson TA,Mensah GA,Alexander RW,et al.Markers of Inflammation and Cardiovascular Disease:Application to Clinical and Public Health Practice:A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association.Circulation,2003,107:499-511

共引文献43

同被引文献14

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部